Clinical trial
Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment
NCT02381730 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- August 31, 2017
- Enrollment
- 37 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.